reglab/statecodes huggingface dataset:
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter Q - REPORTING, TREATMENT AND INVESTIGATION OF CHILD BLOOD LEAD LEVELS › Section 37.336 - Reporting Procedures

Current through Reg. 49, No. 28; July 12, 2024
(a) The
				  reporting physician, laboratory director, or alternate person as set forth in
				  §
										37.335(b)
				  of this title (relating to Persons Required to Report) shall make the report of
				  the child blood lead level results to the Department of State Health Services
				  (department) immediately after receiving the blood lead test result. The
				  department may authorize one or more employees to receive the report from the
				  physician, laboratory director, or alternate person by telephone or fax. The
				  department shall implement a method for verifying the identity of the telephone
				  caller when that person is unfamiliar to the employee.
(b) Transmission also may be made by mail,
				  courier, or electronic transfer.
(1) If by
				  mail or courier, the reports shall be placed in a sealed envelope addressed to
				  the attention of the Department of State Health Services, Childhood Lead
				  Poisoning Prevention Program and marked "confidential medical
				  records."
(2) If by electronic
				  transmission, including facsimile transmission by telephone, it shall be in a
				  manner and form authorized by the commissioner or his or her designee in each
				  instance. Any electronic transmission of the reports must provide at least the
				  same degree of protection against unauthorized disclosure as those of mail or
				  courier transmission.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter Q - REPORTING, TREATMENT AND INVESTIGATION OF CHILD BLOOD LEAD LEVELS › Section 37.337 - Department Rules for Follow-Up Care; Coordination of Care

Current through Reg. 49, No. 28; July 12, 2024
(a) Health care
				  providers should follow the department's Form Pb-109, Physician Reference on
				  Follow-up Testing and Coordination of Care, which may be obtained from the
				  department's website http://www.dshs.state.tx.us/lead or by calling
				  1-800-588-1248, and meets the federal requirements for the recommended schedule
				  for:
(1) obtaining a confirmatory diagnostic
				  venous blood lead test sample; and
(2) providing early and late follow-up care
				  and other activities.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter Q - REPORTING, TREATMENT AND INVESTIGATION OF CHILD BLOOD LEAD LEVELS › Section 37.338 - Environmental Lead Investigations

Current through Reg. 49, No. 28; July 12, 2024
(a) To
				  be eligible for an environmental lead investigation, the child's elevated blood
				  lead level(s) must meet the most recent criteria for environmental
				  investigation issued by the Centers for Disease Control and Prevention of the
				  United States Public Health Service.
(b) The request for an environmental lead
				  investigation shall be on the department's most current form, Pb-101, Request
				  for Environmental Lead Investigation or equivalent. A current version of form
				  Pb-101 may be obtained from the department's website at
				  http://www.dshs.state.tx.us/lead, or by calling 1-800-588-1248. The completed
				  form should be sent by FAX, ATTENTION: Environmental Specialist, using the fax
				  number on the form.
(c) On
				  receiving a report of a child with a confirmed blood lead level warranting an
				  environmental lead investigation, the department or its authorized agent may
				  conduct an environmental lead investigation, using Form Pb-103 (Elevated Blood
				  Lead Level Investigation Questionnaire) or its equivalent, of:
(1) the home environment in which the child
				  resides, or other premises frequented by a child, if the department or the
				  department's authorized agent obtains the written consent of an adult
				  occupant;
(2) any child-care
				  facility with which the child has regular contact and that may be contributing
				  to the child's blood lead level, if the department or the department's
				  authorized agent obtains the written consent of the owner, operator, or
				  principal of the facility; and
(3)
				  any child-occupied facility with which the child has regular contact and that
				  may be contributing to the child's blood lead levels, if the department or the
				  department's authorized agent obtains the written consent of:
(A) the owner, operator, or principal of the
				  facility; or
(B) an adult occupant
				  of the facility if the facility is subject to a lease agreement.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter Q - REPORTING, TREATMENT AND INVESTIGATION OF CHILD BLOOD LEAD LEVELS › Section 37.339 - Environmental Lead Investigations Procedures

Current through Reg. 49, No. 28; July 12, 2024
(a) Eligibility Criteria for Environmental
				  Lead Investigation.
(1) The eligibility
				  criteria for an environmental lead investigation shall be as stated on the
				  department's Form Pb-101, Request for Environmental Lead Investigation or
				  equivalent.
(2) A city, health
				  district, or local health department may conduct an environmental lead
				  investigation using lower elevated blood lead results than those in paragraph
				  (1) of this subsection.
(3) Before
				  conducting the investigation, city, health district, or local health department
				  will:
(A) inform the health care provider of
				  the intent to conduct the investigation; and
(B) submit to the department the most current
				  Form Pb-101, Request for Environmental Lead Investigation or
				  equivalent.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter R - ADVISORY COMMITTEES › Section 37.401 - Maternal Mortality and Morbidity Task Force

Current through Reg. 49, No. 28; July 12, 2024
(a) The committee. The Maternal Mortality and
				  Morbidity Task Force (committee) is appointed under and governed by this
				  section. The committee is established under Texas Health and Safety Code,
				  §§ 34.001 - 34.018.
(b)
				  Purpose. The purpose of the committee is to study cases of pregnancy-related
				  deaths and trends in severe maternal morbidity and to make recommendations to
				  reduce the incidence of pregnancy-related deaths and severe maternal morbidity
				  in Texas.
(c) Tasks. The committee:
(1) studies and reviews:
(A) cases of pregnancy-related
				  deaths;
(B) trends, rates, or
				  disparities in pregnancy-related deaths and severe maternal
				  morbidity;
(C) health conditions
				  and factors that disproportionately affect the most at-risk populations as
				  determined in the joint biennial report required under Texas Health and Safety
				  Code, § 34.015; and
(D) best
				  practices and programs operating in other states that have reduced rates of
				  pregnancy-related deaths;
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter R - ADVISORY COMMITTEES › Section 37.410 - State Child Fatality Review Team Committee

Current through Reg. 49, No. 28; July 12, 2024
(a) The committee. The State Child Fatality
				  Review Team Committee (committee) is appointed under and governed by this
				  section. The committee is established under Texas Family Code, §§
				  264.501 - 264.515.
(b) Purpose. The
				  purpose of the committee is to reduce the number of preventable deaths to
				  children in the State of Texas.
(c)
				  Tasks.
(1) The committee develops an
				  understanding of the causes and incidences of child death in Texas.
(2) The committee identifies procedures
				  within the agencies represented on the committee to reduce the number of
				  preventable child deaths.
(3) The
				  committee promotes public awareness and makes recommendations to the Governor
				  and Texas Legislature for changes in law, policy, and practice to reduce the
				  number of preventable child deaths.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter R - ADVISORY COMMITTEES › Section 37.420 - Sickle Cell Task Force

Current through Reg. 49, No. 28; July 12, 2024
(a) Statutory
				  authority. The Sickle Cell Task Force (Task Force) is established in accordance
				  with Texas Health and Safety Code Chapter 52.
(b) Purpose. The Task Force advises the Texas
				  Department of State Health Services (DSHS) to raise awareness of sickle cell
				  disease and sickle cell trait.
(c)
				  Duties. The Task Force performs duties outlined in Texas Health and Safety Code
				  Chapter 52.
(d) Reporting
				  requirements. By December 1 of each year, the Task Force must submit a written
				  report to the Governor and the Legislature. The report must summarize the Task
				  Force's work and include any recommended actions or policy changes endorsed by
				  the Task Force.
(e) Membership.
(1) The Task Force is composed of seven
				  members appointed by the Texas Health and Human Services (HHS) Executive
				  Commissioner. Membership shall consist of:
(A)
				  two members from community-based organizations with experience addressing the
				  needs of individuals with sickle cell disease;
(B) two physicians specializing in
				  hematology;
(C) two members of the
				  public, each of whom either has sickle cell disease or is a parent of a person
				  with sickle cell disease or trait; and
(D) one representative of a health-related
				  institution.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.501 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
The purpose of this subchapter is to describe the newborn
					 hearing screening process administered by the Department of State Health
					 Services pursuant to Texas Health and Safety Code Chapter 47 to ensure all
					 babies born in Texas receive a hearing screening, proper intervention, and
					 referrals to services if they are suspected or diagnosed as deaf or hard of
					 hearing.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.502 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following words and terms, when used in this
					 subchapter, shall have the following meanings, unless the context clearly
					 indicates otherwise.
(1) Birthing
				  facility:
(A) a hospital licensed under Texas
				  Health and Safety Code Chapter 241 that offers obstetrical services;
(B) a birthing center licensed under Texas
				  Health and Safety Code Chapter 244;
(C) a children's hospital licensed under
				  Texas Health and Safety Code Chapter 241 that offers obstetrical or neonatal
				  intensive care unit services or both; or
(D) a facility maintained or operated by this
				  state or an agency of this state that provides obstetrical services.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.503 - Screening and Consent to Release Individually Identifying Information

Current through Reg. 49, No. 28; July 12, 2024
(a) The birthing
				  facility shall inform the parents during admission that:
(1) the facility is required by law to screen
				  a newborn or infant for hearing loss; and
(2) the parents may decline the
				  screening.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.504 - Required Reporting

Current through Reg. 49, No. 28; July 12, 2024
(a) Any
				  healthcare provider who performs initial hearing screening, follow-up
				  screening, diagnostic evaluations, follow-up care, or interventions is required
				  to report all patient encounters and outcomes, including pass and do not pass
				  results, in the TEHDI MIS within five calendar days after the date of the
				  patient encounter.
(b) If a parent
				  declines the hearing screening for the newborn, the hearing screening refusal
				  must be documented in the medical record and the TEHDI MIS.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.505 - Birthing Facility Screening Provider Responsibilities

Current through Reg. 49, No. 28; July 12, 2024
(a) A birthing facility screening provider
				  shall be a department-certified newborn hearing screening program. A provider
				  that is not certified is required to refer the infant to a department-certified
				  newborn hearing screening program.
(b) A birthing facility screening provider
				  shall:
(1) perform the initial hearing
				  screening, or document why the screening was not performed, in accordance with
				  Texas Health and Safety Code §
											47.003;
(2) provide screening results and educational
				  materials to the parents;
(3)
				  provide screening results to the applicable healthcare providers; and
(4) report results in accordance with §
											37.504
				  of this subchapter (relating to Required Reporting).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.506 - Follow-Up Screening Provider Responsibilities

Current through Reg. 49, No. 28; July 12, 2024
(a) A follow-up screening provider shall:
(1) perform a follow-up screening no later
				  than 30 days after birth;
(2)
				  provide screening results to the applicable healthcare providers;
(3) provide screening results and educational
				  materials to the parents; and
(4)
				  report results in accordance with §
											37.504
				  of this subchapter (relating to Required Reporting).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.507 - Diagnostic Evaluation Provider Responsibilities

Current through Reg. 49, No. 28; July 12, 2024
A diagnostic evaluation provider shall:
(1) perform a diagnostic evaluation no later
				  than three months after birth;
(2)
				  provide results to the parents, applicable healthcare providers, and the
				  resource center;
(3) refer children
				  confirmed as deaf or hard of hearing to ECI within seven days of the encounter;
				  and
(4) report in accordance with
				  §
										37.504
				  of this subchapter (relating to Required Reporting).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.508 - Department Responsibilities

Current through Reg. 49, No. 28; July 12, 2024
(a)
				  The department shall:
(1) maintain the TEHDI
				  MIS;
(2) certify newborn hearing
				  screening programs, as described by program protocol at
https://www.dshs.texas.gov/tehdi/FacilityCertRequire.aspx
;
				  and
(3) make available standardized
				  educational resources.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter S - NEWBORN HEARING SCREENING › Section 37.509 - Authorized Newborn Hearing Services

Current through Reg. 49, No. 28; July 12, 2024
(a) A newborn hearing screening performed by
				  a birthing facility and any related diagnostic follow-up care, provided in
				  accordance with Texas Health and Safety Code Chapter 47 and the requirements of
				  this subchapter, for a newborn who receives medical assistance or who is
				  Medicaid-eligible, is a covered service of the Texas Medical Assistance
				  (Medicaid) Program, in accordance with Texas Human Resources Code Chapter
				  32.
(b) The reimbursement rates and
				  methodology for covered services described in this section shall be established
				  by the Texas Health and Human Services Commission.
(c) Screening for hearing loss from birth
				  through the date the infant is 30 days of age and any diagnostic follow-up care
				  related to the screening from birth through the date the child is 24 months of
				  age, as provided under this subchapter, shall be a covered benefit pursuant to
				  Texas Insurance Code, §§
										1367.101 -
				  1367.103. Co-payments
				  or co-insurance requirements are permitted; however, deductible requirements or
				  dollar limits are prohibited.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.531 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
The purpose of these sections is to establish procedures
					 for awarding grants to assist applicants with the costs of establishing and
					 operating school-based health centers and to establish standards for the funded
					 centers.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.532 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following words and terms, when used in these sections,
					 shall have the following meanings, unless the context clearly indicates
					 otherwise:
(1) Applicant--A school
				  district, charter school, private school, local health department, hospital,
				  health care system, university or non-profit organization applying for a grant
				  from the Department of State Health Services to assist with the costs of
				  establishing and operating a school-based health center.
(2) Primary health services--Family and home
				  support; health care, including immunizations; dental health care; health
				  education; and preventive health strategies.
(3) Department--Department of State Health
				  Services.
(4) Funded applicant--A
				  school district, charter school, private school, local health department,
				  hospital, health care system, university or non-profit organization with which
				  the Department of State Health Services executes a contract to establish and
				  operate a school-based health center.
(5) Grant--A sum of money awarded to a
				  selected applicant on the basis of a Request for Proposals that results in a
				  contract.
(6) Local School Health
				  Advisory Council--Persons appointed by the board of trustees of a school
				  district to make recommendations concerning the establishment and operation of
				  school-based health centers and to assist the district in ensuring that local
				  community values are reflected in the operation of each center. In addition to
				  the majority of appointees who shall be parents of students enrolled in the
				  district or districts, the board of trustees may also appoint at least one
				  person from each of the following groups:
(A)
				  teachers;
(B) school
				  administrators;
(C) licensed health
				  care professionals;
(D) the
				  clergy;
(E) law
				  enforcement;
(F) the business
				  community;
(G) senior citizens;
				  and
(H) students.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.533 - Number of Awards

Current through Reg. 49, No. 28; July 12, 2024
The department shall award grants according to Texas
					 Education Code, §
										38.063.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.534 - Dollar Amount of Awards Per Biennium

Current through Reg. 49, No. 28; July 12, 2024
Grants awarded by the department shall not exceed $250,000
					 per applicant per biennium as required by law.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.535 - Matching Funds

Current through Reg. 49, No. 28; July 12, 2024
Funded applicants shall assure the department that matching
					 funds secured from nonfederal sources, including in-kind contributions,
					 community or foundation grants, individual contributions, and operating funds
					 from local government agencies, shall be available to the school-based health
					 center project.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 37 - MATERNAL AND INFANT HEALTH SERVICES › Subchapter T - SCHOOL-BASED HEALTH CENTERS › Section 37.538 - Standards for School-Based Health Centers

Current through Reg. 49, No. 28; July 12, 2024
(a) Funded applicants shall comply with the
				  following standards for school-based health centers.
(1) Community-based solutions. The funded
				  applicant shall facilitate collaboration among families, schools, and members
				  of the community to assess and meet the health needs of the community's
				  children and families. The funded applicant shall utilize all the following
				  strategies for facilitating community-based solutions:
(A) Establish or utilize a local school
				  health advisory council per Education Code, Title 2, Chapter 28, §28.004
				  to make recommendations on the establishment and operation of school-based
				  health centers and to assist the district in ensuring that local community
				  values are reflected in the operation of each center and in the provision of
				  health education.
(B) Establish
				  and/or enhance links between school personnel, school-based health center
				  personnel, other health/social services providers and agencies in the
				  community, and other supportive community sectors.
(C) Enable students and families to be
				  responsible decision-makers in promoting their own health and well-being,
				  making connections with community systems that help to prevent the social
				  isolation and alienation of individuals and families, and using the health care
				  system wisely.
(D) Require parental
				  involvement in and management of the health care of children receiving services
				  from the center; encourage parental accompaniment of any child younger than 18
				  years of age at visits to the center; notify the child's parent at least one
				  week in advance or as early as possible of the scheduled appointment; and
				  encourage the parent to attend the appointment.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.1 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
The purpose of this subchapter is to establish minimum
					 standards for administering, maintaining, and disposing of epinephrine
					 auto-injectors for an institution of higher education that adopts unassigned
					 epinephrine auto-injector policies. These standards are implemented under Texas
					 Education Code, Chapter 51, Subchapter Y-1 and Texas Health and Safety Code,
					 Chapter 773, Subchapter A.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.2 - Voluntary Unassigned Epinephrine Auto-injector Policies for an Institution of Higher Education

Current through Reg. 49, No. 28; July 12, 2024
An institution of higher education (institution) may adopt
					 and implement a written policy regarding the maintenance, administration, and
					 disposal of unassigned epinephrine auto-injectors at each institution's campus.
					 If a written policy is adopted under this subchapter, the policy must comply
					 with Texas Education Code, §
										51.882 or Texas Health
					 and Safety Code, §
										773.0145, and
					 this subchapter.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.3 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following terms and phrases, when used in this
					 subchapter, shall have the following meanings, unless the context clearly
					 indicates otherwise:
(1)
				  Anaphylaxis--As defined in Texas Education Code, §
										51.881.
(2) Authorized healthcare provider--A
				  physician, as defined in Texas Education Code, §
										51.881, or person who
				  has been delegated prescriptive authority by a physician under Texas
				  Occupations Code, Chapter 157 as described in Texas Health and Safety Code,
				  §
										773.0145.
(3) Campus--An educational unit under the
				  management and control of an institution of higher education and may include,
				  in addition to the main campus, off-campus and secondary locations, such as
				  branch campuses, teaching locations, regional centers, and where students are
				  housed.
(4) Institution of Higher
				  Education--As defined in Texas Education Code, §
										61.003(8) and
				  (15).
(5) Personnel--Employees of an institution of
				  higher education who are authorized and trained to administer epinephrine
				  auto-injectors.
(6) Unassigned
				  epinephrine auto-injector--An epinephrine auto-injector prescribed by an
				  authorized healthcare provider in the name of the institution of higher
				  education issued with a non-patient-specific standing delegation order for the
				  administration of an epinephrine auto-injector, and issued by an authorized
				  healthcare provider.
(7)
				  Volunteer--A person who is providing services for or on behalf of an
				  institution of higher education on the premises of the institution's campus, at
				  an institution of higher education-sponsored event or an institution of higher
				  education-related activity on or off institution property, and who does not
				  receive compensation in excess of reimbursement for expenses and is authorized
				  and trained to administer an epinephrine auto-injector.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.4 - Applicability

Current through Reg. 49, No. 28; July 12, 2024
This subchapter applies to any institution of higher
					 education (institution) that voluntarily chooses to adopt and implement a
					 written policy regarding the maintenance, administration, and disposal of
					 unassigned epinephrine auto-injectors on each institution's
					 campus.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.5 - Maintenance, Administration, and Disposal of Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) An
				  institution of higher education (institution) shall obtain a prescription from
				  an authorized healthcare provider each year to stock, possess, and maintain at
				  least one unassigned adult epinephrine auto-injector pack (two doses) on each
				  institution's campus as described in Texas Education Code, §
										51.885 and Texas
				  Health and Safety Code, §
										773.0145. The
				  number of additional adult packs may be determined by an individual campus
				  assessment led by an authorized healthcare provider, based on available
				  resources.
(b) An institution
				  performing an assessment may consider:
(1)
				  consultation with campus police, office of risk management, office of food
				  services, office of housing, office of health services, or any department
				  involved with student well-being;
(2) campus geography, including high risk
				  areas; and
(3) student population
				  size.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.6 - Training

Current through Reg. 49, No. 28; July 12, 2024
(a) Each
				  institution of higher education (institution) that adopts an unassigned
				  epinephrine auto-injector written policy under this subchapter is responsible
				  for training institution personnel and institution volunteers in the
				  recognizing of anaphylaxis signs and symptoms and hands-on administration of an
				  unassigned epinephrine auto-injector.
(b) Training shall be consistent with the
				  most recent Voluntary Guidelines for Managing Food Allergies in Schools and
				  Early Care and Education Programs published by the federal Centers for Disease
				  Control and Prevention.
(c) Each
				  institution shall maintain training records and each public institution shall
				  make available upon request a list of those institution personnel or
				  institution volunteers trained and authorized to administer the unassigned
				  epinephrine auto-injector on the campus.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.7 - Report on Administering Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) Records
				  relating to implementing and administrating the institution of higher education
				  (institution) unassigned epinephrine auto-injector policy shall be retained per
				  the record retention schedule for records of institutions of higher education
				  found in 13 TAC §
										6.10.
(b) The institution shall submit a report no
				  later than the 10th business day after the date institution personnel or an
				  institution volunteer administers an epinephrine auto-injector in accordance
				  with the unassigned epinephrine auto-injector policy adopted under this
				  subchapter. The report shall be submitted to the institution and those
				  identified in Texas Education Code, §
										51.883.
(c) Notifications to the commissioner of the
				  Department of State Health Services (DSHS) shall be submitted on the designated
				  electronic form available on DSHS's School Health Program website found at
				  dshs.texas.gov.
(d) This section
				  does not apply to a private or independent institution of higher education, as
				  defined in Texas Education Code, §
										61.003(15).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter A - EPINEPHRINE AUTO-INJECTOR POLICIES IN INSTITUTIONS OF HIGHER EDUCATION › Section 40.8 - Immunity from Liability

Current through Reg. 49, No. 28; July 12, 2024
A person who in good faith takes, or fails to take, any
					 action under this subchapter or Texas Education Code, Chapter 51, Subchapter
					 Y-1 or Texas Health and Safety Code, Chapter 773, Subchapter A, is immune from
					 civil or criminal liability or disciplinary action resulting from that action
					 or failure to act in accordance with the Texas Education Code, §
										51.888 or Texas Health
					 and Safety Code, §
										773.0145.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.11 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
The purpose of this subchapter is to establish minimum
					 standards for administering, maintaining, and disposing of epinephrine
					 auto-injectors for a specified entity that adopts an unassigned epinephrine
					 auto-injector policy. These standards are implemented under Texas Health and
					 Safety Code, Chapter 773, Subchapter A.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.12 - Voluntary Unassigned Epinephrine Auto-injector Policies for Certain Entities

Current through Reg. 49, No. 28; July 12, 2024
Specified entities may adopt and implement a written policy
					 regarding the maintenance, administration, and disposal of unassigned
					 epinephrine auto-injectors at each venue's property. The adopted policy must
					 comply with the standards outlined in Texas Health and Safety Code §
										773.0145 and
					 this subchapter.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.13 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following terms and phrases, when used in this
					 subchapter, shall have the following meanings, unless the context clearly
					 indicates otherwise:
(1)
				  Anaphylaxis--As defined in Texas Education Code §
										51.881.
(2) Authorized healthcare provider--A
				  physician or person who has been delegated prescriptive authority by a
				  physician under Texas Occupations Code Chapter 157, as described in Texas
				  Health and Safety Code §
										773.0145.
(3) Personnel--Employees and volunteers of a
				  venue.
(4) Unassigned epinephrine
				  auto-injector--An epinephrine auto-injector prescribed by an authorized
				  healthcare provider in the name of the venue issued with a non-patient-specific
				  standing order for the administration of an epinephrine
				  auto-injector.
(5) Venue--An entity
				  offering a place of public gathering including:
(A) an amusement park, as defined by Texas
				  Penal Code §
											46.035;
(B) a restaurant, as defined by Texas
				  Business and Commerce Code §
											17.821;
				  or
(C) a sports venue, as defined
				  by Texas Local Government Code §
											504.151.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.14 - Applicability

Current through Reg. 49, No. 28; July 12, 2024
This subchapter applies to any venue that voluntarily
					 adopts and implements a written policy regarding the maintenance,
					 administration, and disposal of unassigned epinephrine auto-injectors at each
					 venue.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.15 - Maintenance, Administration, and Disposal of Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) A
				  venue shall obtain a prescription and standing order from an authorized
				  healthcare provider each year to stock, possess, and maintain at least one
				  unassigned adult epinephrine auto-injector pack (two doses) on each venue's
				  property, as described in Texas Health and Safety Code §
										773.0145. The
				  number of additional adult packs may be determined by an individual venue
				  assessment led by an authorized health-care provider, based on available
				  resources.
(b) A venue performing
				  such an assessment may consider:
(1)
				  consultation with office of risk management, office of food services, or any
				  department involved with public well-being;
(2) venue geography, including high risk
				  areas; and
(3) venue occupancy
				  limit.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.16 - Training

Current through Reg. 49, No. 28; July 12, 2024
(a) Each venue that
				  adopts an unassigned epinephrine auto-injector written policy under this
				  subchapter is responsible for training venue personnel and venue volunteers in
				  the recognizing of anaphylaxis signs and symptoms and hands-on administration
				  of an unassigned epinephrine auto-injector.
(b) Training shall be consistent with the
				  most recent Voluntary Guidelines for Managing Food Allergies in Schools and
				  Early Care and Education Programs published by the federal Centers for Disease
				  Control and Prevention.
(c) Each
				  venue shall maintain training records and each venue shall make available upon
				  request a list of those venue personnel or venue volunteers trained and
				  authorized to administer the unassigned epinephrine auto-injector on the
				  venue's property.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.17 - Report on Administering Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) The venue that
				  adopts a policy for administering unassigned epinephrine auto-injectors shall
				  submit a report no later than the 10th business day after the date an
				  epinephrine auto-injection is administered, in accordance with the unassigned
				  epinephrine auto-injector policy adopted under this subchapter. The report
				  shall be submitted to the prescribing authorized healthcare provider and the
				  Department of State Health Services (DSHS).
(b) Notifications to the commissioner of DSHS
				  shall be submitted on the designated electronic form available on the DSHS
				  School Health Program website, available at dshs.texas.gov.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter B - EPINEPHRINE AUTO-INJECTOR POLICIES IN CERTAIN ENTITIES › Section 40.18 - Immunity from Liability

Current through Reg. 49, No. 28; July 12, 2024
A person who in good faith takes, or fails to take, any
					 action under this subchapter or Texas Health and Safety Code, Chapter 773,
					 Subchapter A, is immune from civil or criminal liability or disciplinary action
					 resulting from that action or failure to act in accordance with the Texas
					 Health and Safety Code §
										773.0145.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.21 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
The purpose of this subchapter is to establish minimum
					 standards for administering, maintaining, and disposing of epinephrine
					 auto-injectors for a youth facility that adopts unassigned epinephrine
					 auto-injector policies. These standards are implemented under Texas Health and
					 Safety Code, Chapter 773, Subchapter A.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.22 - Voluntary Unassigned Epinephrine Auto-injector Policies for Youth Facilities

Current through Reg. 49, No. 28; July 12, 2024
A youth facility may voluntarily adopt and implement a
					 written policy regarding the maintenance, administration, and disposal of
					 unassigned epinephrine auto-injectors at each youth facility. If a written
					 policy is adopted under this subchapter, the policy must comply with Texas
					 Health and Safety Code, §
										773.0145, and
					 this subchapter.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.23 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following terms and phrases, when used in this
					 subchapter, shall have the following meanings, unless the context clearly
					 indicates otherwise:
(1)
				  Anaphylaxis--As defined in Texas Human Resources Code, §
										42.067.
(2) Authorized healthcare provider--A
				  physician, or person who has been delegated prescriptive authority by a
				  physician under Texas Occupations Code, Chapter 157 as described in Texas
				  Health and Safety Code, §
										773.0145.
(3) Personnel--Employees or volunteers of a
				  youth facility.
(4) Unassigned
				  epinephrine auto-injector--An epinephrine auto-injector prescribed by an
				  authorized healthcare provider in the name of the youth facility, issued with a
				  non-patient-specific standing order for the administration of an epinephrine
				  auto-injector.
(5) Youth facility
				  is:
(A) a child-care facility, as defined by
				  Texas Human Resources Code, §
											42.002;
(B) a day camp or youth camp, as defined by
				  Texas Health and Safety Code, §
											141.002;
(C) a youth center, as defined by Texas
				  Health and Safety Code, §
											481.134;
(D) a small employer-based day-care facility,
				  as defined by Texas Human Resources Code, §
											42.151;
(E) a temporary shelter day-care facility, as
				  defined by Texas Human Resources Code, §
											42.201;
(F) a listed family home, as defined by Texas
				  Human Resources Code, §
											42.052(c);
				  or
(G) any other private or public
				  entity that would benefit from the possession and administration of epinephrine
				  auto-injectors, that provide services for youth under the age of
				  eighteen.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.24 - Applicability

Current through Reg. 49, No. 28; July 12, 2024
This subchapter applies to any youth facility that
					 voluntarily chooses to adopt and implement a written policy regarding the
					 maintenance, administration, and disposal of unassigned epinephrine
					 auto-injectors.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.25 - Maintenance, Administration, and Disposal of Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) A
				  youth facility (facility) shall stock at least one unassigned pediatric
				  epinephrine auto-injector pack (two doses) and one adult epinephrine
				  auto-injector pack (two doses). The number of additional pediatric and adult
				  packs may be determined by a facility assessment led by an authorized
				  health-care provider, based on available resources, in accordance with this
				  subchapter.
(b) A facility with
				  greater than 100 youth and staff that voluntarily adopts an unassigned
				  epinephrine auto-injector policy shall conduct an assessment to determine the
				  minimum number of additional unassigned epinephrine auto-injectors and may
				  consider as a part of an assessment:
(1)
				  consultation with administrators, office of risk management, food services
				  management, or any department involved with public well-being;
(2) facility geography, including high risk
				  areas where food exposure or environmental trigger exposure may
				  occur;
(3) enrollment limit and
				  number of personnel; and
(4) the
				  number of youth with an identified allergy.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.26 - Training

Current through Reg. 49, No. 28; July 12, 2024
(a) Each youth
				  facility (facility) that adopts an unassigned epinephrine auto-injector written
				  policy under this subchapter is responsible for annually training personnel to
				  recognize the signs and symptoms of anaphylaxis and to perform hands-on
				  administration of an unassigned epinephrine auto-injector.
(b) Training shall be consistent with the
				  most recent Voluntary Guidelines for Managing Food Allergies in Schools and
				  Early Care and Education Programs published by the federal Centers for Disease
				  Control and Prevention.
(c) Each
				  facility shall maintain and make available upon request:
(1) a list of personnel trained and
				  authorized to administer the unassigned epinephrine auto-injector;
				  and
(2) annual training records for
				  such personnel.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 40 - STOCK MEDICATION IN SCHOOLS AND OTHER ENTITIES › Subchapter C - EPINEPHRINE AUTO-INJECTOR POLICIES IN YOUTH FACILITIES › Section 40.27 - Report on Administering Unassigned Epinephrine Auto-Injectors

Current through Reg. 49, No. 28; July 12, 2024
(a) The youth
				  facility (facility) shall submit a report no later than the 10th business day
				  after the date facility personnel administer an unassigned epinephrine
				  auto-injector. The report shall be submitted to the owner of the facility, the
				  prescribing authorized healthcare provider, and the Department of State Health
				  Services (DSHS).
(b) Notifications
				  to DSHS shall be submitted on the designated electronic form available on
				  DSHS's School Health Program website found at dshs.texas.gov. DSHS will submit
				  a copy of the report to the Child Care Regulation Department of the Texas
				  Health and Human Services Commission.